Skip to content
Shenzhen Oriental PharmaceuticalShenzhen Oriental PharmaceuticalOrientalSpecialty APIs since 1995
← Back to products

Dorzolamide HCL

Ophthalmic

Overview

A topical carbonic anhydrase inhibitor for lowering intraocular pressure in glaucoma and ocular hypertension.

Specifications

CAS130693-82-2
StandardUSP
CategoryAPI
Regulatory filesAvailable on request
Therapeutic areaOphthalmic

Regulatory support

Available under NDA for qualified products.

Safety Data Sheet (SDS) & CoA

An SDS and a representative CoA are available for every catalogue product. For your compliance or qualification file, request them by email or the RFQ form — our team releases them together with the documentation package you need.

Request the SDS & CoA by email

Impurity reference standards for this API 7

We also synthesize the pharmacopeial and process impurities of this API (identified by CAS number — the only reliable key). Browse them or request the list by email.

See its impurity standards

Request documentation & quotation

Specify your target market and annual volume; we'll reply with the relevant dossier and price.

Ask for the dossier
GMPUS FDA inspectedUSP